Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples